Seelos Therapeutics, Inc.: capex
| Value | {"amount": 500000, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"} |
|---|---|
| Period | 2014-01-01 – 2014-09-30 |
| Status | current |
| Entity | Seelos Therapeutics, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T09:53:11.864121+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/d3961cfc-c895-4baa-81fa-89f770da7f5d
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001017491-14-000103 · Open the official SEC filing →Retrieved: 2026-08-19T09:53:11.864121+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001017491/capex/2014-09-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/d3961cfc-c895-4baa-81fa-89f770da7f5d
History
- no predecessors — first report